Cdex, Inc. (fka CDEX)

[capnmike]

Crow, your ignorance of parenteral potency issues becomes more evident with every question you publish. Just 'google' what you just asked and it will save you bringing focus where your misinformed beliefs are rooted.

What if a manufacturer of pharmaceutical products has a CFO (financial money person) look at some sort of loss or minimization of profits when some product is no longer used because assumption of potency changes. With the incredible DRUG SHORTAGE issues going on and visible in the news, there are impacts and high interest regarding potency and shelf life etc. There are also..... well, I wont go further.

I will partially answer your question at the bottom with just ONE example.

http://cdex-inc.com/cdex-ships-valimed-g4-medication-validation-system/

CDEX Ships ValiMed G4 Medication Validation SystemOctober 3, 2011, by Marketing, Posted in Press Releases, Comments Off
Prominent Global Medical Technology Company to Use for Research and DevelopmentTUCSON, AZ–(Marketwire – Oct 3, 2011) – CDEX Inc. (OTCBB: CEXI), a leading developer of chemical detection products, using patented technologies for use in healthcare, safety and security markets, announced today the company has shipped the first ValiMed™ G4 drug validation system to a prominent US based global medical technology company. The company intends using the ValiMed G4 as a lab instrument for a research and development project to determine the shelf life of parenteral admixtures with regards to potency over time.

=========================

Now Crow3, I just KNOW you are NOT trying to mislead people. You ask...

....what event would trigger questioning a drip bag and make a potency test desirable or required?

I tell you, this is a significant issue, and financial impacts and potential increase in profits are in the balance. Now, here is just one thing in response...

http://onlinelibrary.wiley.com/doi/10.1111/j.1471-0528.2001.00014.x/full

Studies7–10 have questioned the potency of injectable oxytocics in tropical climates. Financial constraints may also prevent both their routine use and proper storage.